Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility

References

• Abi–Said, D, Anaissie, E, Uzun, O, Raad, I, Pinzcowski, H, and Vartivarian, S 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24, 1122–8.
   PubMed Web of Science ®Google Scholar
• Agatensi, L, Franchi, F, Mondello, F, Bevilacqua, R L, Ceddia, T, De Bernardis, F, and Cassone, A 1991. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J Clin Pathol 44, 826–30.
   PubMed Web of Science ®Google Scholar
• Almirante, B, Rodriguez, D, Cuenca–Estrella, M, Almela, M, Sanchez, F, Ayats, J, Alonso–Tarres, C, Rodriguez–Tudela, J L, and Pahissa, A 2006. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case–control population–based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 44, 1681–5.
   PubMed Web of Science ®Google Scholar
• Amici, G, Grandesso, S, Mottola, A, Virga, G, Calconi, G, and Bocci, C 1994. Fungal peritonitis in peritoneal dialysis: critical review of six cases. Adv Perit Dial 10, 169–73.
   PubMedGoogle Scholar
• Andriole, V T, and Hasenclever, H F 1962. Factors influencing experimental candidiasis in mice I Alloxan diabetes. Yale J Biol Med 35, 96–112.
   PubMed Web of Science ®Google Scholar
• Arendrup, M, Horn, T, and Frimodt–Moller, N 2002. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30, 286–91.
   PubMed Web of Science ®Google Scholar
• Arevalo, M P, Carrillo–Munoz, A J, Salgado, J, Cardenes, D, Brio, S, Quindos, G, and Espinel–Ingroff, A 2003. Antifungal activity of the echinocandin anidulafungin (VER002, LY–303366). against yeast pathogens: a comparative study with M27–A microdilution method. J Antimicrob Chemother 51, 163–6.
   PubMed Web of Science ®Google Scholar
• Arias, A, Arevalo, M P, Andreu, A, Rodriguez, C, and Sierra, A 1994. In vitro susceptibility of 545 isolates of Candida spp to four antifungal agents. Mycoses 37, 285–9.
   PubMed Web of Science ®Google Scholar
• Ashford, B 1928. Certain conditions of the gastrointestinal tract in Puerto Rico and their relation to tropical sprue. Am J Trop Med Hyg 8, 507–38.
   Google Scholar
• Aybay, C, and Imir, T 1996. Tumor necrosis factor (TNF). induction from monocyte/macrophages by Candida species. Immunobiol. 196, 363–74.
   PubMed Web of Science ®Google Scholar
• Baley, J E, and Silverman, R A 1988. Systemic candidiasis: cutaneous manifestations in low birth weight infants. Pediatrics 82, 211–5.
   PubMed Web of Science ®Google Scholar
• Banerjee, S N, Emori, T G, Culver, D H, Gaynes, R P, Jarvis, W R, Horan, T, Edwards, J R, Tolson, J, Henderson, T, and Martone, W J 1991. Secular trends in nosocomial primary bloodstream infections in the United States 1980–1989 National Nosocomial Infections Surveillance System. Am J Med 91, 86S–89S.
   PubMed Web of Science ®Google Scholar
• Barchiesi, F, Caggiano, G, Falconi Di Francesco, L, Montagna, M T, Barbuti, S, and Scalise, G 2004. Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit. Diagn Microbiol Infect Dis 49, 269–71.
   PubMed Web of Science ®Google Scholar
• Barchiesi, F, Spreghini, E, Tomassetti, S, Della Vittoria, A, Arzeni, D, Manso, E, and Scalise, G 2006. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis. Antimicrob Agents Chemother 50, 2719–27.
   PubMed Web of Science ®Google Scholar
• Barchiesi, F, Spreghini, E, Tomassetti, S, Giannini, D, and Scalise, G 2007. Caspofungin in combination with amphotericin B against Candida parapsilosis. Antimicrob Agents Chemother 51, 941–5.
   PubMed Web of Science ®Google Scholar
• Bayer, A S, Witt, M D, Kim, E, and Ghannoum, M A 1996. Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non–C albicans strains. Antimicrob Agents Chemother 40, 494–6.
   PubMed Web of Science ®Google Scholar
• Beck–Sague, C, and Jarvis, W R 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980–1990 National Nosocomial Infections Surveillance System. J Infect Dis 167, 1247–51.
   PubMed Web of Science ®Google Scholar
• Bendel, C M 2003. Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin Perinatol 27, 357–64.
   PubMed Web of Science ®Google Scholar
• Benjamin, D K, Jr, Ross, K, McKinney, R E, Jr, Benjamin, D K, Auten, R, and Fisher, R G 2000. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase–negative staphylococcal bacteremia. Pediatrics 106, 712–8.
   PubMed Web of Science ®Google Scholar
• Bille, J, and Glauser, M P 1997. Evaluation of the susceptibility of pathogenic Candida species to fluconazole Fluconazole Global Susceptibility Study Group. Eur J Clin Microbiol Infect Dis 16, 924–8.
   PubMed Web of Science ®Google Scholar
• Bistoni, F, Vecchiarelli, A, Cenci, E, Sbaraglia, G, Perito, S, and Cassone, A 1984. A comparison of experimental pathogenicity of Candida species in cyclophosphamide immunodepressed mice. Sabouraudia 22, 409–18.
   PubMedGoogle Scholar
• Bonassoli, L A, Bertoli, M, and Svidzinski, T I 2005. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect 59, 159–62.
   PubMed Web of Science ®Google Scholar
• Bourcier, T, Touzeau, O, Thomas, F, Chaumeil, C, Baudrimont, M, Borderie, V, and Laroche, L 2003. Candida parapsilosis keratitis. Cornea 22, 51–5.
   PubMed Web of Science ®Google Scholar
• Branchini, M L, Pfaller, M A, Rhine–Chalberg, J, Frempong, T, and Isenberg, H D 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 32, 452–6.
   PubMed Web of Science ®Google Scholar
• Brandstetter, R D, and Brause, B D 1980. Candida parapsilosis endocarditis Recovery of the causative organism from an addict’s own syringes. JAMA 243, 1073.
   PubMed Web of Science ®Google Scholar
• Bren, A 1998. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 17, 839–43.
   PubMed Web of Science ®Google Scholar
• Brilhante, R S, Cordeiro, R A, Medrano, D J, Rocha, M F, Monteiro, A J, Cavalcante, C S, Meireles, T E, and Sidrim, J J 2005. Onychomycosis in Ceara (Northeast Brazil): epidemiological and laboratory aspects. Mem Inst Oswaldo Cruz 100, 131–5.
   PubMed Web of Science ®Google Scholar
• Brooks, D H, and Pupparo, F 1998. Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty 13, 707–12.
   PubMed Web of Science ®Google Scholar
• Brummer, E, Hanson, L H, and Stevens, D A 1991. Kinetics and requirements for activation of macrophages for fungicidal activity: effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism. Cell Immunol 132, 236–45.
   PubMed Web of Science ®Google Scholar
• Brummer, E, and Stevens, D A 1989. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma–interferon. J Med Microbiol 28, 173–81.
   PubMed Web of Science ®Google Scholar
• Brummer, E, and Stevens, D A in press. Collectins and fungal pathogens: role of surfactant proteins and mannose binding lectin in host resistance. Med Mycol.
   Google Scholar
• Camacho, D P, Gasparetto, A, and Svidzinski, T I 2007. The effect of chlorhexidine and gentian violet on the adherence of Candida spp to urinary catheters. Mycopathologia 163, 261–6.
   PubMed Web of Science ®Google Scholar
• Camougrand, N, Mila, B, Velours, G, Lazowska, J, and Guerin, M 1988. Discrimination between different groups of Candida parapsilosis by mitochondrial DNA restriction analysis. Curr Genet 13, 445–9.
   PubMed Web of Science ®Google Scholar
• Camougrand, N, Velours, G, and Guerin, M 1986. Resistance of Candida parapsilosis to drugs. Biol Cell 58, 71–8.
   PubMed Web of Science ®Google Scholar
• Campbell, J R, Zaccaria, E, and Baker, C J 2000. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case–control study. Pediatrics 105, 1041–5.
   PubMed Web of Science ®Google Scholar
• Cano, M V, Perz, J F, Craig, A S, Liu, M, Lyon, G M, Brandt, M E, Lott, T J, Lasker, B A, Barrett, F F, McNeil, M M, Schaffner, W, and Hajjeh, R A 2005. Candidemia in pediatric outpatients receiving home total parenteral nutrition. Med Mycol 43, 219–25.
   PubMed Web of Science ®Google Scholar
• Capilla, J, Clemons, K V, and Stevens, D A 2007. Animal models: an important tool in mycology. Med Mycol 45, 657–84.
   PubMed Web of Science ®Google Scholar
• Capoor, M R, Nair, D, Deb, M, Verma, P K, Srivastava, L, and Aggarwal, P 2005. Emergence of non–albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis 58, 344–8.
   PubMed Web of Science ®Google Scholar
• Cappelletty, D, and Eiselstein–McKitrick, K 2007. The echinocandins. Pharmacother 27, 369–88.
   PubMed Web of Science ®Google Scholar
• Carruba, G, Pontieri, E, De Bernardis, F, Martino, P, and Cassone, A 1991. DNA fingerprinting and electrophoretic karyotype of environmental and clinical isolates of Candida parapsilosis. J Clin Microbiol 29, 916–22.
   PubMed Web of Science ®Google Scholar
• Cassone, A, De Bernardis, F, Mondello, F, Ceddia, T, and Agatensi, L 1987. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 156, 777–83.
   PubMed Web of Science ®Google Scholar
• Cassone, A, De Bernardis, F, Pontieri, E, Carruba, G, Girmenia, C, Martino, P, Fernandez–Rodriguez, M, Quindos, G, and Ponton, J 1995. Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J Infect Dis 171, 967–75.
   PubMed Web of Science ®Google Scholar
• Chamilos, G, Lewis, R E, Albert, N, and Kontoyiannis, D P 2007. Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin–specific and Candida species–related differences. Antimicrob Agents Chemother 51, 2257–9.
   PubMed Web of Science ®Google Scholar
• Chamilos, G, Lewis, R E, and Kontoyiannis, D P 2006a. Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin. Antimicrob Agents Chemother 50, 744–7.
   PubMed Web of Science ®Google Scholar
• Chamilos, G, Lionakis, M S, Lewis, R E, Lopez–Ribot, J L, Saville, S P, Albert, N D, Halder, G, and Kontoyiannis, D P 2006b. Drosophila melanogaster as a facile model for large–scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 193, 1014–22.
   PubMed Web of Science ®Google Scholar
• Chapman, R L 2007. Prevention and treatment of Candida infections in neonates. Semin Perinatol 31, 39–46.
   PubMed Web of Science ®Google Scholar
• Chen, C M, Ho, M W, Yu, W L, and Wang, J H 2004. Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin–bag disconnect system. J Microbiol Immunol Infect 37, 115–20.
   PubMedGoogle Scholar
• Chen, K H, Chang, C T, Yu, C C, Huang, J Y, Yang, C W, and Hung, C C 2006. Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis patients. Ren Fail 28, 241–6.
   PubMed Web of Science ®Google Scholar
• Clark, T A, Slavinski, S A, Morgan, J, Lott, T, Arthington–Skaggs, B A, Brandt, M E, Webb, R M, Currier, M, Flowers, R H, Fridkin, S K, and Hajjeh, R A 2004. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol 42, 4468–72.
   PubMed Web of Science ®Google Scholar
• Clemons, K V, Espiritu, M, Parmar, R and Stevens, D A 2006. Assessment of the paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob Agents Chemother 50, 1293–7.
   PubMed Web of Science ®Google Scholar
• Clerihew, L, Lamagni, T L, Brocklehurst, P, and McGuire, W 2007. Candida parapsilosis infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 92, F127–9.
   PubMed Web of Science ®Google Scholar
• Cuende, E, Barbadillo, C R E M, Isasi, C, Trujillo, A, and Andreu, J L 1993. Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum 22, 224–41.
   PubMed Web of Science ®Google Scholar
• Cushing, R D, and Fulgenzi, W R 1997. Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response. J Arthroplasty 12, 950.
   PubMed Web of Science ®Google Scholar
• da Silva, C L, dos Santos, R M, and Colombo, A L 2001. Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit. Braz J Infect Dis 5, 32–6.
   PubMedGoogle Scholar
• Dagdeviren, M, Cerikcioglu, N, and Karavus, M 2005. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses 48, 321–6.
   PubMed Web of Science ®Google Scholar
• Damjanovic, V, Connolly, C M, van Saene, H K, Cooke, R W, Corkill, J E, van Belkum, A, and van Velzen, D 1993. Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24, 245–59.
   PubMed Web of Science ®Google Scholar
• Dassanayake, R S, and Samaranayake, L P 2000. Characterization of the genetic diversity in superficial and systemic human isolates of Candida parapsilosis by randomly amplified polymorphic DNA (RAPD). APMIS 108, 153–60.
   PubMed Web of Science ®Google Scholar
• De Bernardis, F, Lorenzini, R, Morelli, L, and Cassone, A 1989a. Experimental rat vaginal infection with Candida parapsilosis. FEMS Microbiol Lett 53, 137–41.
   PubMedGoogle Scholar
• De Bernardis, F, Lorenzini, R, Verticchio, R, Agatensi, L, and Cassone, A 1989b. Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis. J Clin Microbiol 27, 2598–603.
   PubMed Web of Science ®Google Scholar
• De Bernardis, F, Mondello, F, San Millan, R, Ponton, J, and Cassone, A 1999. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol 37, 3481–6.
   PubMed Web of Science ®Google Scholar
• De Clerck, L, Dequeker, J, Westhovens, R, and Hauglustaine, D 1988. Candida parapsilosis in a patient receiving chronic hemodialysis. J Rheumatol 15, 372–4.
   PubMed Web of Science ®Google Scholar
• Denning, D W 2003. Echinocandin antifungal drugs. Lancet 362, 1142–51.
   PubMed Web of Science ®Google Scholar
• Deresinski, S C, Clemons, K V, Kemper, C A, Roesch, K, Walton, B, and Stevens, D A 1995. Genotypic analysis of pseudoepidemic due to contamination of Hanks’ balanced salt solution with Candida parapsilosis J Clin Microbiol 33, 2224–6.
   PubMed Web of Science ®Google Scholar
• Diekema, D J, Messer, S A, Brueggemann, A B, Coffman, S L, Doern, G V, Herwaldt, L. A, and Pfaller, M A 2002. Epidemiology of candidemia: 3–year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 40, 1298–302.
   PubMed Web of Science ®Google Scholar
• Diekema, D J, Messer, S A, Hollis, R J, Wenzel, R P, and Pfaller, M A 1997. An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn Microbiol Infect Dis 29, 147–53.
   PubMed Web of Science ®Google Scholar
• Diekema, D J, Pfaller, M A, Messer, S A, Houston, A, Hollis, R J, Doern, G V, and Jones, R N 1999. In vitro activities of BMS–207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. Antimicrob Agents Chemother 43, 2236–9.
   PubMed Web of Science ®Google Scholar
• Djeridane, A, Djeridane, Y, and Ammar–Khodja, A 2006. Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria. Mycoses 49, 190–6.
   PubMed Web of Science ®Google Scholar
• Djeridane, A, Djeridane, Y, and Ammar–Khodja, A 2007. A clinicomycological study of fungal foot infections among Algerian military personnel. Clin Exp Dermatol 32, 60–3.
   PubMed Web of Science ®Google Scholar
• Dorko, E, Baranova, Z, Jenca, A, Kizek, P, Pilipcinec, E, and Tkacikova, L 2005. Diabetes mellitus and candidiases. Folia Microbiol (Praha). 50, 255–61.
   PubMed Web of Science ®Google Scholar
• Dorko, E, Jautova, J, Tkacikova, L, and Wantrubova, A 2002a. The frequency of Candida species in onychomycosis. Folia Microbiol (Praha). 47, 727–31.
   PubMed Web of Science ®Google Scholar
• Dorko, E, Jenca, A, Orencak, M, Viragova, S, and Pilipcinec, E 2004. Otomycoses of candidal origin in eastern Slovakia. Folia Microbiol (Praha). 49, 601–4.
   PubMed Web of Science ®Google Scholar
• Dorko, E, Pilipcinec, E, and Tkacikova, L 2002b. Candida species isolated from cerebrospinal fluid. Folia Microbiol (Praha). 47, 179–81.
   PubMed Web of Science ®Google Scholar
• Douglas, L J 2003. Candida biofilms and their role in infection. Trends Microbiol 11, 30–6.
   PubMed Web of Science ®Google Scholar
• Edmond, M B, Wallace, S E, McClish, D K, Pfaller, M A, Jones, R N, and Wenzel, R P 1999. Nosocomial bloodstream infections in United States hospitals: a three–year analysis. Clin Infect Dis 29, 239–44.
   PubMed Web of Science ®Google Scholar
• Edwards, J E, Jr, Montgomerie, J Z, Ishida, K, Morrison, J O, and Guze, L B 1977. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis 135, 294–7.
   PubMed Web of Science ®Google Scholar
• Eggimann, P, Garbino, J, and Pittet, D 2003. Epidemiology of Candida species infections in critically ill non–immunosuppressed patients. Lancet Infect Dis 3, 685–702.
   PubMed Web of Science ®Google Scholar
• Enger, L, Joly, S, Pujol, C, Simonson, P, Pfaller, M, and Soll, D R 2001. Cloning and characterization of a complex DNA fingerprinting probe for Candida parapsilosis. J Clin Microbiol 39, 658–69.
   PubMed Web of Science ®Google Scholar
• Faix, R G 1983. Candida parapsilosis meningitis in a premature infant. Pediatr Infect Dis 2, 462–4.
   PubMedGoogle Scholar
• Faix, R G 1984. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr 105, 616–22.
   PubMed Web of Science ®Google Scholar
• Faix, R G 1992. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 11, 88–93.
   PubMed Web of Science ®Google Scholar
• Feman, S S, Nichols, J C, Chung, S M, and Theobald, T A 2002. Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 100, 67–70; discussion 70–1.
   PubMedGoogle Scholar
• Fenn, J P, Segal, H, Barland, B, Denton, D, Whisenant, J, Chun, H, Christofferson, K, Hamilton, L, and Carroll, K 1994. Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J Clin Microbiol 32, 1184–7.
   PubMed Web of Science ®Google Scholar
• Fidel, P L, Jr, Vazquez, J A, and Sobel, J D 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C albicans. Clin Microbiol Rev 12, 80–96.
   PubMed Web of Science ®Google Scholar
• Figueiredo, V T, de Assis Santos, D, Resende, M A, and Hamdan, J S 2007. Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp responsible for fingernail infections. Mycopathologia 164, 27–33.
   PubMed Web of Science ®Google Scholar
• Fleck, R, Dietz, A, and Hof, H 2007. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother 59, 767–71.
   PubMed Web of Science ®Google Scholar
• Fluckiger, U, Marchetti, O, Bille, J, Eggimann, P, Zimmerli, S, Imhof, A, Garbino, J, Ruef, C, Pittet, D, Tauber, M, Glauser, M, and Calandra, T 2006. Treatment options of invasive fungal infections in adults. Swiss Med Wkly 136, 447–63.
   PubMed Web of Science ®Google Scholar
• Forrest, G N, Weekes, E, and Johnson, J K 2008. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infection 56, 126–9
   Google Scholar
• Fundyga, R E, Kuykendall, R J, Lee–Yang, W, and Lott, T J 2004. Evidence for aneuploidy and recombination in the human commensal yeast Candida parapsilosis. Infect Genet Evol 4, 37–43.
   PubMed Web of Science ®Google Scholar
• Fusek, M, Smith, E A, Monod, M, and Foundling, S I 1993. Candida parapsilosis expresses and secretes two aspartic proteinases. FEBS Lett 327, 108–12.
   PubMed Web of Science ®Google Scholar
• Gacser, A, Schafer, W, Nosanchuk, J S, Salomon, S, and Nosanchuk, J D 2007a. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol 44, 1336–41.
   PubMed Web of Science ®Google Scholar
• Gacser, A, Trofa, D, Schafer, W, and Nosanchuk, J D 2007b. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest 117, 3049–3058.
   PubMed Web of Science ®Google Scholar
• Galgiani, J N, and Stevens, D A 1977. Fungal endocarditis: need for guidelines in evaluating therapy Experience with two patients previously reported. J Thorac Cardiovasc Surg 73, 293–6.
   PubMed Web of Science ®Google Scholar
• Garcia San Miguel, L, Pla, J, Cobo, J, Navarro, F, Sanchez–Sousa, A, Alvarez, M E, Martos, I, and Moreno, S 2004. Morphotypic and genotypic characterization of sequential Candida parapsilosis isolates from an outbreak in a pediatric intensive care unit. Diagn Microbiol Infect Dis 49, 189–96.
   PubMed Web of Science ®Google Scholar
• Garcia–Effron, G, Katiyar, S K, Park, S, Edlind, T D, and Perlin, D S 2008. A naturally occurring proline–to–alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52, 2305–12.
   PubMed Web of Science ®Google Scholar
• Garcia–Martos, P, Delgado, D, Marin, P, and Mira, J 1993. Analysis of 40 cases of otomycosis. Enferm Infecc Microbiol Clin 11, 487–9.
   PubMedGoogle Scholar
• Garzoni, C, Nobre, V A, and Garbino, J 2007. Candida parapsilosis endocarditis: a comparative review of the literature. Eur J Clin Microbiol Infect Dis 26, 915–26.
   PubMed Web of Science ®Google Scholar
• Gautret, P, Kauffmann–Lacroix, C, Rodier, MH, Kull, E, Charron, M, Silvain, C, & Jacquemin, JL 1998. Molecular typing of Candida parapsilosis isolated from a patient undergoing a fungal pancreatitis. J Mycol Med 8, 188–91.
   Web of Science ®Google Scholar
• Ghannoum, M A 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13, 122–43.
   PubMed Web of Science ®Google Scholar
• Girmenia, C, Martino, P, De Bernardis, F, Gentile, G, Boccanera, M, Monaco, M, Antonucci, G, and Cassone, A 1996. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 23, 506–14.
   PubMed Web of Science ®Google Scholar
• Gokce, G, Cerikcioglu, N, and Yagci, A 2007. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia 164, 265–9.
   PubMed Web of Science ®Google Scholar
• Gomez–Lopez, A, Alastruey–Izquierdo, A, Rodriguez, D, Almirante, B, Pahissa, A, Rodriguez–Tudela, J, and Cuenca–Estrella, M 2008. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis Results from population–based surveillance of candidemia in Spain. Antimicrob Agents Chemother 52, 1506–1509.
   PubMed Web of Science ®Google Scholar
• Gupta, A K, and Shear, N H 2000. A risk–benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Safety 22, 33–52.
   PubMed Web of Science ®Google Scholar
• Hawser, S P, and Douglas, L J 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62, 915–21.
   PubMed Web of Science ®Google Scholar
• Heelan, J S, Sotomayor, E, Coon, K, and D’Arezzo, J B 1998. Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species. J Clin Microbiol 36, 1443–5.
   PubMed Web of Science ®Google Scholar
• Hennessy, M J 1996. Infection of a total knee arthroplasty by Candida parapsilosis A case report of successful treatment by joint reimplantation with a literature review. Am J Knee Surg 9, 133–6.
   PubMedGoogle Scholar
• Hobson, R P 2003. The global epidemiology of invasive Candida infections—is the tide turning?. J Hosp Infect 55, 159–68.
   PubMed Web of Science ®Google Scholar
• Hogasen, A K, Abrahamsen, T G, and Gaustad, P 1995. Various Candida and Torulopsis species differ in their ability to induce the production of C3, factor B and granulocyte–macrophage colony–stimulating factor (GM–CSF). in human monocyte cultures. J Med Microbiol 42, 291–8.
   PubMed Web of Science ®Google Scholar
• Horn, R, Wong, B, Kiehn, T E, and Armstrong, D 1985. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 7, 646–55.
   PubMedGoogle Scholar
• Hostetter, M K 1994. Adhesins and ligands involved in the interaction of Candida spp with epithelial and endothelial surfaces. Clin Microbiol Rev 7, 29–42.
   PubMed Web of Science ®Google Scholar
• Howlett, J A 1976. The infection of rat tongue mucosa in vitro with five species of Candida. J Med Microbiol 9, 309–16.
   PubMed Web of Science ®Google Scholar
• Huang, Y C, Li, C C, Lin, T Y, Lien, R I, Chou, Y H, Wu, J L, and Hsueh, C 1998. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 17, 819–22.
   PubMed Web of Science ®Google Scholar
• Huang, Y C, Lin, T Y, Leu, H S, Peng, H L, Wu, J H, and Chang, H Y 1999. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection 27, 97–102.
   PubMed Web of Science ®Google Scholar
• Huang, Y C, Lin, T Y, Lien, R I, Chou, Y H, Kuo, C Y, Yang, P H, and Hsieh, W S 2000. Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection. J Infect 40, 171–5.
   PubMed Web of Science ®Google Scholar
• Huang, Y C, Su, L H, Wu, T L, and Lin, T Y 2004. Genotyping analysis of colonizing candidal isolates from very–low–birthweight infants in a neonatal intensive care unit. J Hosp Infect 58, 200–3.
   PubMed Web of Science ®Google Scholar
• Huttova, M, Hartmanova, I, Kralinsky, K, Filka, J, Uher, J, Kurak, J, Krizan, S, and Krcmery, V, Jr, 1998a. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr Infect Dis J 17, 1012–5.
   PubMed Web of Science ®Google Scholar
• Huttova, M, Kralinsky, K, Horn, J, Marinova, I, Iligova, K, Fric, J, Spanik, S, Filka, J, Uher, J, Kurak, J, and Krcmery, V, Jr, 1998b. Prospective study of nosocomial fungal meningitis in children—report of 10 cases. Scand J Infect Dis 30, 485–7.
   PubMedGoogle Scholar
• Ibanez, R, and Serrano–Heranz, R 1999. Pancreatic infection with Candida parapsilosis. Scand J Infect Dis 31, 415–6.
   PubMedGoogle Scholar
• Ibrahim, A S, Mirbod, F, Filler, S G, Banno, Y, Cole, G T, Kitajima, Y, Edwards, J E, Jr, Nozawa, Y, and Ghannoum, M A 1995. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63, 1993–8.
   PubMed Web of Science ®Google Scholar
• Iida, S, Imai, T, Oguri, T, Okuzumi, K, Yamanaka, A, Moretti–Branchini, M L, Nishimura, K, and Mikami, Y 2005. Genetic diversity of the internal transcribed spacers (ITS). and 5.8S rRNA genes among the clinical isolates of Candida parapsilosis in Brazil and Japan. Jpn J Med Mycol 46, 133–7.
   Google Scholar
• Ip, W K, and Lau, Y L 2004. Role of mannose–binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J Infect Dis 190, 632–40.
   PubMed Web of Science ®Google Scholar
• Jack, D L, and Turner, M W 2003. Anti–microbial activities of mannose–binding lectin. Biochem Soc Trans 31, 753–7.
   PubMed Web of Science ®Google Scholar
• Jarvis, W R 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20, 1526–30.
   PubMed Web of Science ®Google Scholar
• Jautova, J, Viragova, S, Ondrasovic, M, and Holoda, E 2001. Incidence of Candida species isolated from human skin and nails: a survey. Folia Microbiol (Praha). 46, 333–7.
   PubMed Web of Science ®Google Scholar
• Jimenez–Mejias, M E, Moreno–Maqueda, I, Regordan, C, and Artola–Igarza, J L 1993. External cerebrospinal fluid diversion and Candida parapsilosis meningitis Treatment with fluconazole. Med Clin Barc. 100, 156.
   PubMed Web of Science ®Google Scholar
• Johnson, R J, Ramsey, P G, Gallagher, N, and Ahmad, S 1985. Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis. Am J Nephrol 5, 169–75.
   PubMed Web of Science ®Google Scholar
• Johnston, B L, Schlech, W F, 3rd & Marrie, T J 1994. An outbreak of Candida parapsilosis prosthetic valve endocarditis following cardiac surgery. J Hosp Infect 28, 103–12.
   PubMed Web of Science ®Google Scholar
• Kaitwatcharachai, C 2002. Candida parapsilosis peritonitis in patients on CAPD. Mycopathologia 154, 181–4.
   PubMed Web of Science ®Google Scholar
• Kao, A S, Brandt, M E, Pruitt, W R, Conn, L A, Perkins, B A, Stephens, D S, Baughman, W S, Reingold, A L, Rothrock, G A, Pfaller, M A, Pinner, R W, and Hajjeh, R A 1999. The epidemiology of candidemia in two United States cities: results of a population–based active surveillance. Clin Infect Dis 29, 1164–70.
   PubMed Web of Science ®Google Scholar
• Katragkou, A, Chatzimoschou, A, Simitsopoulou, M, Dalakiouridou, M, Diza–Mataftsi, E, Tsantali, C, and Roilides, E 2008. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 52, 357–60.
   PubMed Web of Science ®Google Scholar
• Kauffman, C A, Bradley, S F, and Vine, A K 1993. Candida endophthalmitis associated with intraocular lens implantation: efficacy of fluconazole therapy. Mycoses 36, 13–7.
   PubMed Web of Science ®Google Scholar
• Kaufman, D, Boyle, R, Hazen, K C, Patrie, J T, Robinson, M, and Donowitz, L G 2001. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345, 1660–6.
   PubMed Web of Science ®Google Scholar
• Khan, M U, Ali, S, Baig, M A, Rafiq, M A, Vasavada, B C, and Khan, I A 2007. Candida parapsilosis endocarditis 8 months after transient candidemia. Int J Cardiol 118, e58–9.
   PubMedGoogle Scholar
• Khosravi, A R, and Mansouri, P 2001. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole. Mycopathologia 150, 9–13.
   PubMed Web of Science ®Google Scholar
• Kicklighter, S D, Springer, S C, Cox, T, Hulsey, T C, and Turner, R B 2001. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 107, 293–8.
   PubMed Web of Science ®Google Scholar
• Klotz, S A, Drutz, D J, Harrison, J L, and Huppert, M 1983. Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun 42, 374–84.
   PubMed Web of Science ®Google Scholar
• Koklu, E, Gunes, T, Kurtoglu, S, Gokoglu, S, and Koklu, S 2007. Onychomycosis in a premature infant caused by Candida parapsilosis. Pediatr Dermatol 24, 155–6.
   PubMed Web of Science ®Google Scholar
• Kosa, P, Gavenciakova, B, and Nosek, J 2007. Development of a set of plasmid vectors for genetic manipulations of the pathogenic yeast Candida parapsilosis. Gene 396, 338–45.
   PubMed Web of Science ®Google Scholar
• Kosa, P, Valach, M, Tomaska, L, Wolfe, K H, and Nosek, J 2006. Complete DNA sequences of the mitochondrial genomes of the pathogenic yeasts Candida orthopsilosis and Candida metapsilosis: insight into the evolution of linear DNA genomes from mitochondrial telomere mutants. Nucleic Acids Res 34, 2472–81.
   PubMed Web of Science ®Google Scholar
• Kossoff, E H, Buescher, E S, and Karlowicz, M G 1998. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17, 504–8.
   PubMed Web of Science ®Google Scholar
• Kovacicova, G, Krupova, Y, Lovaszova, M, Roidova, A, Trupl, J, Liskova, A, Hanzen, J, Milosovic, P, Lamosova, M, Macekova, L, Szovenyiova, Z, Purgelova, A, Obertik, T, Bille, J, and Krcmery, V 2000. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non–cancer patient population: is there a correlation between in–vitro resistance to fluconazole and the outcome of fungemia?. J Infect Chemother 6, 216–21.
   PubMedGoogle Scholar
• Krcmery, V, and Barnes, A J 2002. Non–albicans Candida spp causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50, 243–60.
   PubMed Web of Science ®Google Scholar
• Krcmery, V, Huttova, M, Mateicka, F, Laho, L, Jurga, L, Ondrusova, A, Tarekova, Z, Kralinsky, K, Hanzen, J, Liskova, A, Mrazova, M, Sabo, A, Pisarcikova, M, Kovacicova, G, Chovancova, D, and Szovenyiova, Z 2001. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro. J Antimicrob Chemother 48, 521–5.
   PubMed Web of Science ®Google Scholar
• Krcmery, V, Jr, Mrazova, M, Kunova, A, Grey, E, Mardiak, J, Jurga, L, Sabo, A, Sufliarsky, J, Sevcikova, L, Sorkovska, D, West, D, Trupl, J, Novotny, J, and Mateicka, F 1999. Nosocomial candidaemias due to species other than Candida albicans in cancer patients Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. Support Care Cancer 7, 428–31.
   PubMed Web of Science ®Google Scholar
• Kuhn, D M, Mikherjee, P K, Clark, T A, Pujol, C, Chandra, J, Hajjeh, R A, Warnock, D W, Soil, D R, and Ghannoum, M A 2004. Candida parapsilosis characterization in an outbreak setting. Emerg Infect Dis 10, 1074–81.
   PubMed Web of Science ®Google Scholar
• Kull, E, Ripault, M P, Gautret, P, Kauffman–Lacroix, C, and Silvain, C 1999. Pancreatic necrosis infection by Candida parapsilosis associated with fungemia. Gastroenterol Clin Biol 23, 978–80.
   PubMedGoogle Scholar
• Kurtzman, C P, and Robnett, C J 1998. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S). ribosomal DNA partial sequences. Antonie Van Leeuwenhoek 73, 331–71.
   PubMed Web of Science ®Google Scholar
• Laffey, S F, and Butler, G 2005. Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiol. 151, 1073–81.
   PubMed Web of Science ®Google Scholar
• Lasker, B A, Butler, G, and Lott, T J 2006. Molecular genotyping of Candida parapsilosis group I clinical isolates by analysis of polymorphic microsatellite markers. J Clin Microbiol. 44, 750–9.
   PubMed Web of Science ®Google Scholar
• Laverdiere, M, Labbe, A C, Restieri, C, Rotstein, C, Heyland, D, Madger, S, and Stewart, T 2007. Susceptibility patterns of Candida species recovered from Canadian intensive care units. J Crit Care 22, 245–50.
   PubMed Web of Science ®Google Scholar
• Legout, L, Assal, M, Rohner, P, Lew, D, Bernard, L, and Hoffmeyer, P 2006. Successful treatment of Candida parapsilosis (fluconazole–resistant). osteomyelitis with caspofungin in a HIV patient. Scand J Infect Dis 38, 728–30.
   PubMed Web of Science ®Google Scholar
• Lehmann, P F, Lin, D, and Lasker, B A 1992. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 30, 3249–54.
   PubMed Web of Science ®Google Scholar
• Levin, A S, Costa, S F, Mussi, N S, Basso, M, Sinto, S I, Machado, C, Geiger, D C, Villares, M C, Schreiber, A Z, Barone, A A, and Branchini, M L 1998. Candida parapsilosis fungemia associated with implantable and semi–implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis 30, 243–9.
   PubMed Web of Science ®Google Scholar
• Levy, I, Rubin, L G, Vasishtha, S, Tucci, V, and Sood, S K 1998. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 26, 1086–8.
   PubMed Web of Science ®Google Scholar
• Li, Y N, Shi, J Q, and Huang, W M 1988. Folliculitis caused by Candida parapsilosis. Int J Dermatol 27, 522–3.
   PubMed Web of Science ®Google Scholar
• Lillegard, J B, Sim, R B, Thorkildson, P, Gates, M A, and Kozel, T R 2006. Recognition of Candida albicans by mannan–binding lectin in vitro and in vivo. J Infect Dis 193, 1589–97.
   PubMed Web of Science ®Google Scholar
• Lin, D, Wu, L C, Rinaldi, M G, and Lehmann, P F 1995. Three distinct genotypes within Candida parapsilosis from clinical sources. J Clin Microbiol 33, 1815–21.
   PubMed Web of Science ®Google Scholar
• Lockhart, S R, Messer, S A, Pfaller, M A, and Diekema, D J 2008a. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol 46, 2659–64.
   PubMed Web of Science ®Google Scholar
• Lockhart, S R, Messer, S A, Pfaller, M A, and Diekema, D J 2008b. Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections. J Clin Microbiol 46, 374–6.
   PubMed Web of Science ®Google Scholar
• Logue, M E, Wong, S, Wolfe, K H, and Butler, G 2005. A genome sequence survey shows that the pathogenic yeast Candida parapsilosis has a defective MTLa1 allele at its mating type locus. Eukaryot Cell 4, 1009–17.
   PubMedGoogle Scholar
• Longman, L P, Hibbert, S A, and Martin, M V 1990. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis. Rev Infect Dis 12, Suppl 3, S294–8.
   PubMedGoogle Scholar
• Lopez–Ciudad, V, Castro–Orjales, M J, Leon, C, Sanz–Rodriguez, C, de la Torre–Fernandez, M J, Perez de Juan–Romero, M A, Collell–Llach, M D, and Diaz–Lopez, M D 2006. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infect Dis 6, 73.
   PubMed Web of Science ®Google Scholar
• Lott, T J, Kuykendall, R J, Welbel, S F, Pramanik, A, and Lasker, B A 1993. Genomic heterogeneity in the yeast Candida parapsilosis. Curr Genet 23, 463–7.
   PubMed Web of Science ®Google Scholar
• Lyman, C A, and Walsh, T J 1994. Phagocytosis of medically important yeasts by polymorphonuclear leukocytes. Infect Immun 62, 1489–93.
   PubMed Web of Science ®Google Scholar
• Manzano–Gayosso, P, Hernandez–Hernandez, F, Mendez–Tovar, L J, Gonzalez–Monroy, J, and Lopez–Martinez, R 2003. Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD). Mycoses 46, 425–9.
   PubMed Web of Science ®Google Scholar
• Marais, E, Stewart, R, Duse, A G, Rosekilly, I C, de Jong, G, and Aithma, N 2004. Candida parapsilosis detected in TPN using the BacT/Alert system and characterized by randomly amplified polymorphic DNA. J Hosp Infect 56, 291–6.
   PubMed Web of Science ®Google Scholar
• Marangon, F B, Miller, D, Giaconi, J A, and Alfonso, E C 2004. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 137, 820–5.
   PubMed Web of Science ®Google Scholar
• Marco, F, Danes, C, Almela, M, Jurado, A, Mensa, J, de la Bellacasa, J P, Espasa, M, Martinez, J A, and Jimenez de Anta, M T 2003. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates Results from a six–year study (1996–2001). Diagn Microbiol Infect Dis 46, 259–64.
   PubMed Web of Science ®Google Scholar
• Marco, F, Pfaller, M A, Messer, S A, and Jones, R N 1998. Activity of MK–0991 (L743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp. Diagn Microbiol Infect Dis 32, 33–7.
   PubMed Web of Science ®Google Scholar
• Marodi, L, Forehand, J R, and Johnston, R B, Jr, 1991a. Mechanisms of host defense against Candida species II Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 146, 2790–4.
   PubMed Web of Science ®Google Scholar
• Marodi, L, Korchak, H M, and Johnston, R B, Jr 1991b. Mechanisms of host defense against Candida species I Phagocytosis by monocytes and monocyte–derived macrophages. J Immunol 146, 2783–9.
   PubMed Web of Science ®Google Scholar
• Matthews, R C, Rigg, G, Hodgetts, S, Carter, T, Chapman, C, Gregory, C, Illidge, C, and Burnie, J 2003. Preclinical assessment of the efficacy of Mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother 47, 2208–16.
   PubMed Web of Science ®Google Scholar
• McCray, E, Rampell, N, Solomon, S L, Bond, W W, Martone, W J, and O’Day, D 1986. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol 24, 625–8.
   PubMed Web of Science ®Google Scholar
• McCullough, M J, Ross, B C, and Reade, P C 1996. Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation. Int J Oral Maxillofac Surg 25, 136–44.
   PubMed Web of Science ®Google Scholar
• McGinley, K J, Larson, E L, and Leyden, J J 1988. Composition and density of microflora in the subungual space of the hand. J Clin Microbiol 26, 950–3.
   PubMed Web of Science ®Google Scholar
• Mellado, E, Cuenca–Estrella, M, Regadera, J, Gonzalez, M, Diaz–Guerra, T M, and Rodriguez–Tudela, J L 2000. Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. Diagn Microbiol Infect Dis 38, 21–8.
   PubMed Web of Science ®Google Scholar
• Melo, A S, Colombo, A L, and Arthington–Skaggs, B A 2007. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 51, 3081–8.
   PubMed Web of Science ®Google Scholar
• Merkerova, M, Dostal, J, Hradilek, M, Pichova, I, and Hruskova–Heidingsfeldova, O 2006. Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis. FEMS Yeast Res 6, 1018–26.
   PubMed Web of Science ®Google Scholar
• Messer, S A, Kirby, J T, Sader, H S, Fritsche, T R, and Jones, R N 2004. Initial results from a longitudinal international surveillance programme for anidulafungin (2003). J Antimicrob Chemother 54, 1051–6.
   PubMed Web of Science ®Google Scholar
• Meunier–Carpentier, F, Kiehn, T E, and Armstrong, D 1981. Fungemia in the immunocompromised host changing patterns, antigenemia, high mortality. Am J Med 71, 363–70.
   PubMed Web of Science ®Google Scholar
• Mokaddas, E M, Al–Sweih, N A, and Khan, Z U 2007. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10–year study. J Med Microbiol 56, 255–9.
   PubMed Web of Science ®Google Scholar
• Mora–Duarte, J, Betts, R, Rotstein, C, Colombo, A L, Thompson–Moya, L, Smietana, J, Lupinacci, R, Sable, C, Kartsonis, N, and Perfect, J 2002. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347, 2020–9.
   PubMed Web of Science ®Google Scholar
• Muallem, M S, Alfonso, E C, Romano, A C, Miller, D, Kurstin, J, Marangon, F B, Culbertson, W W, and Yoo, S H 2003. Bilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis. J Cataract Refract Surg 29, 2022–5.
   PubMed Web of Science ®Google Scholar
• Mujica, M T, Finquelievich, J L, Jewtuchowicz, V, and Iovannitti, C A 2004. Prevalence of Candida albicans and Candida non–albicans in clinical samples during 1999–2001. Rev Argent Microbiol 36, 107–12.
   PubMedGoogle Scholar
• Naglik, J, Albrecht, A, Bader, O, and Hube, B 2004. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6, 915–26.
   PubMed Web of Science ®Google Scholar
• Nakamura, T, and Takahashi, H 2006. Epidemiological study of Candida infections in blood: susceptibilities of Candida spp to antifungal agents, and clinical features associated with the candidemia. J Infect Chemother 12, 132–8.
   PubMedGoogle Scholar
• Nett, J, Lincoln, L, Marchillo, K, and Andes, D 2007. Beta –1,3 glucan as a test for central venous catheter biofilm infection. J Infect Dis 195, 1705–12.
   PubMed Web of Science ®Google Scholar
• Nguyen, M H, Peacock, J E, Jr, Morris, A J, Tanner, D C, Nguyen, M L, Snydman, D R, Wagener, M M, Rinaldi, M G, and Yu, V L 1996. The changing face of candidemia: emergence of non–Candida albicans species and antifungal resistance. Am J Med 100, 617–23.
   PubMed Web of Science ®Google Scholar
• Nosek, J, Adamikova, L, Zemanova, J, Tomaska, L, Zufferey, R, and Mamoun, C B 2002a. Genetic manipulation of the pathogenic yeast Candida parapsilosis. Curr Genet 42, 27–35.
   PubMed Web of Science ®Google Scholar
• Nosek, J, Novotna, M, Hlavatovicova, Z, Ussery, D W, Fajkus, J, and Tomaska, L 2004. Complete DNA sequence of the linear mitochondrial genome of the pathogenic yeast Candida parapsilosis. Mol Genet Genomics 272, 173–80.
   PubMed Web of Science ®Google Scholar
• Nosek, J, Tomaska, L, Rycovska, A, and Fukuhara, H 2002b. Mitochondrial telomeres as molecular markers for identification of the opportunistic yeast pathogen Candida parapsilosis. J Clin Microbiol 40, 1283–9.
   PubMed Web of Science ®Google Scholar
• Nucci, M, Santos, L M, AS, F, and Colombo, A L 2001. Epidemiology of candidemia due to Candida parapsilosis in tertiary care hospitals in Brazil In Interscience conference on antimicrobial agents and chemotherapy, abstr. J-1623.
   Google Scholar
• Nyirjesy, P, Alexander, A B, and Weitz, M V 2005. Vaginal Candida parapsilosis: pathogen or bystander?. Infect Dis Obstet Gynecol 13, 37–41.
   PubMedGoogle Scholar
• O’Day, D M 1985. Value of a centralized surveillance system during a national epidemic of endophthalmitis. Ophthalmology 92, 309–15.
   PubMed Web of Science ®Google Scholar
• O’Day, D M, Head, W S, and Robinson, R D 1987. An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility. Br J Ophthalmol 71, 126–9.
   PubMed Web of Science ®Google Scholar
• Odio, C M, Araya, R, Pinto, L E, Castro, C E, Vasquez, S, Alfaro, B, Saenz, A, Herrera, M L, and Walsh, T J 2004. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J 23, 1093–7.
   PubMed Web of Science ®Google Scholar
• Oliveira, A C, Shinobu, C S, Longhini, R, Franco, S L, and Svidzinski, T I 2006. Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions. Mem Inst Oswaldo Cruz 101, 493–7.
   PubMed Web of Science ®Google Scholar
• Ostrosky–Zeichner, L, Rex, J H, Pappas, P G, Hamill, R J, Larsen, R A, Horowitz, H W, Powderly, W G, Hyslop, N, Kauffman, C A, Cleary, J, Mangino, J E, and Lee, J 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 47, 3149–54.
   PubMed Web of Science ®Google Scholar
• Panagoda, G J, Ellepola, A N, and Samaranayake, L P 2001. Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity. Mycoses 44, 29–35.
   PubMed Web of Science ®Google Scholar
• Pappas, P G, Rex, J H, Lee, J, Hamill, R J, Larsen, R A, Powderly, W, Kauffman, C A, Hyslop, N, Mangino, J E, Chapman, S, Horowitz, H W, Edwards, J E, and Dismukes, W E 2003. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37, 634–43.
   PubMed Web of Science ®Google Scholar
• Pappas, P G, Rex, J H, Sobel, J D, Filler, S G, Dismukes, W E, Walsh, T J, and Edwards, J. E 2004. Guidelines for treatment of candidiasis. Clin Infect Dis 38, 161–89.
   PubMed Web of Science ®Google Scholar
• Park, S, Kelly, R, Kahn, J N, Robles, J, Hsu, M J, Register, E, Li, W, Vyas, V, Fan, H, Abruzzo, G, Flattery, A, Gill, C, Chrebet, G, Parent, S A, Kurtz, M, Teppler, H, Douglas, C M, and Perlin, D S 2005. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates. Antimicrob Agents Chemother 49, 3264–73.
   PubMed Web of Science ®Google Scholar
• Passos, X S, Sales, W S, Maciel, P J, Costa, C R, Miranda, K C, Lemos Jde, A, Batista Mde, A, and Silva Mdo, R, 2005. Candida colonization in intensive care unit patients’ urine. Mem Inst Oswaldo Cruz 100, 925–8.
   PubMed Web of Science ®Google Scholar
• Peman, J, Canton, E, and Gobernado, M 2005. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2–year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 24, 23–30.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A 1995. Epidemiology of candidiasis J Hosp Infect 30 Suppl, 329–38.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A 2004. Anidulafungin: an echinocandin antifungal. Expert Opin Investig Drugs 13, 1183–97.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Boyken, L, Hollis, R J, Kroeger, J, Messer, S A, Tendolkar, S, and Diekema, D. J 2008a.. In vitro susceptibility of invasive isolates of Candida spp to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46, 150–6.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Boyken, L, Hollis, R J, Messer, S A, Tendolkar, S, and Diekema, D J 2005a. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp, including 315 isolates resistant to fluconazole. J Clin Microbiol 43, 5425–7.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Boyken, L, Hollis, R J, Messer, S A, Tendolkar, S, and Diekema, D J 2006a. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI–recommended methods. J Clin Microbiol 44, 3533–8.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Boyken, L, Hollis, R J, Messer, S A, Tendolkar, S, and Diekema, D J 2006b. In vitro susceptibilities of Candida spp to caspofungin: four years of global surveillance. J Clin Microbiol 44, 760–3.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Boyken, L, Messer, S A, Tendolkar, S, Hollis, R J, and Diekema, D J 2005b. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. J Clin Microbiol 43, 5208–13.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, and Diekema, D J 2002. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 40, 3551–7.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, and Diekema, D J 2004. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 10, Suppl 1, 11–23.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Diekema, D J, Gibbs, D L, Newell, V A, Meis, J F, Gould, I M, Fu, W, Colombo, A L, and Rodriguez–Noriega, E 2007. Results from the ARTEMIS DISK Global Antifungal Surveillance study 1997 to 2005: an 8.5–year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 45, 1735–45.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Diekema, D J, Gibbs, D L, Newell, V A, Ng, K P, Colombo, A, Finquelievich, J, Barnes, R, and Wadula, J 2008b. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program 2001 to 2005. J Clin Microbiol 46, 842–9.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Diekema, D J, Jones, R N, Messer, S A, and Hollis, R J 2002. Trends in antifungal susceptibility of Candida spp isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program 1997 to 2000. J Clin Microbiol 40, 852–6.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Diekema, D J, Rinaldi, M G, Barnes, R, Hu, B, Veselov, A V, Tiraboschi, N, Nagy, E, and Gibbs, D L 2005c. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5–year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 43, 5848–59.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Jones, R N, Doern, G V, Fluit, A C, Verhoef, J, Sader, H S, Messer, S A, Houston, A, Coffman, S, and Hollis, R J 1999. International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents SENTRY Participant Group Europe.. Diagn Microbiol Infect Dis 35, 19–25.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Jones, R N, Doern, G V, Sader, H S, Hollis, R J, and Messer, S A 1998a. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program The SENTRY Participant Group. J Clin Microbiol 36, 1886–9.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Jones, R N, Doern, G V, Sader, H S, Messer, S A, Houston, A, Coffman, S, and Hollis, R J 2000. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America 1997–1998. Antimicrob Agents Chemother 44, 747–51.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Jones, R N, Messer, S A, Edmond, M B, and Wenzel, R P 1998b. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 30, 121–9.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Messer, S A, and Coffman, S 1997. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob Agents Chemother 41, 763–6.
   PubMed Web of Science ®Google Scholar
• Pfaller, M A, Messer, S A, and Hollis, R J 1995. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn Microbiol Infect Dis 21, 9–14.
   PubMed Web of Science ®Google Scholar
• Pichova, I, Pavlickova, L, Dostal, J, Dolejsi, E, Hruskova–Heidingsfeldova, O, Weber, J, Ruml, T, and Soucek, M 2001. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae inhibition with peptidomimetic inhibitors. Eur J Biochem 268, 2669–77.
   PubMedGoogle Scholar
• Pontieri, E, Caracciolo, C, Bianchini, S, Dantonio, D, Novelli, G, Dallapiccola, B, and Carruba, G 2001. Single primer pair for PCR identification of Candida parapsilosis group I isolates. J Med Microbiol 50, 441–8.
   PubMed Web of Science ®Google Scholar
• Posteraro, B, Bruno, S, Boccia, S, Ruggiero, A, Sanguinetti, M, Romano Spica, V, Ricciardi, G, and Fadda, G 2004. Candida parapsilosis bloodstream infection in pediatric oncology patients: results of an epidemiologic investigation. Infect Control Hosp Epidemiol 25, 641–5.
   PubMed Web of Science ®Google Scholar
• Potoka, D A, Takao, S, Owaki, T, Bulkley, G B, and Klein, A S 1998. Endothelial cells potentiate oxidant–mediated Kupffer cell phagocytic killing. Free Radic Biol Med 24, 1217–27.
   PubMed Web of Science ®Google Scholar
• Ramage, G, Saville, S P, Thomas, D P, and Lopez–Ribot, J L 2005. Candida biofilms: an update. Eukaryot Cell 4, 633–8.
   PubMed Web of Science ®Google Scholar
• Ramani, R, Gromadzki, S, Pincus, D H, Salkin, I F, and Chaturvedi, V 1998. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J Clin Microbiol 36, 3396–8.
   PubMed Web of Science ®Google Scholar
• Rangel–Frausto, M S, Wiblin, T, Blumberg, H M, Saiman, L, Patterson, J, Rinaldi, M, Pfaller, M, Edwards, J E, Jr, Jarvis, W, Dawson, J, and Wenzel, R P 1999. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29, 253–8.
   PubMed Web of Science ®Google Scholar
• Reboli, A C, Rotstein, C, Pappas, P G, Chapman, S W, Kett, D H, Kumar, D, Betts, R, Wible, M, Goldstein, B P, Schranz, J, Krause, D S, and Walsh, T J 2007. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356, 2472–82.
   PubMed Web of Science ®Google Scholar
• Rex, J H, Pfaller, M A, Barry, A L, Nelson, P W, and Webb, C D 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother 39, 40–4.
   PubMed Web of Science ®Google Scholar
• Robbins, E G, 2nd, Stollman, N H, Bierman, P, Grauer, L, and Barkin, J S 1996. Pancreatic fungal infections: a case report and review of the literature. Pancreas 12, 308–12.
   PubMed Web of Science ®Google Scholar
• Rodriguez, D, Almirante, B, Park, B J, Cuenca–Estrella, M, Planes, A M, Sanchez, F, Gene, A, Xercavins, M, Fontanals, D, Rodriguez–Tudela, J L, Warnock, D W, and Pahissa, A 2006. Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J 25, 224–9.
   PubMed Web of Science ®Google Scholar
• Rodriguez–Soto, M E, Fernandez–Andreu, C M, Moya Duque, S, Rodriguez Diaz, R M, and Martinez–Machin, G 1993. Clinico–mycological study of onychomycosis in elderly patients. Rev Inst Med Trop Sao Paulo 35, 213–7.
   PubMedGoogle Scholar
• Roilides, E, Farmaki, E, Evdoridou, J, Dotis, J, Hatziioannidis, E, Tsivitanidou, M, Bibashi, E, Filioti, I, Sofianou, D, Gil–Lamaignere, C, Mueller, F M, and Kremenopoulos, G 2004. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 23, 745–50.
   PubMed Web of Science ®Google Scholar
• Roilides, E, Holmes, A, Blake, C, Pizzo, P A, and Walsh, T J 1995a. Effects of granulocyte colony–stimulating factor and interferon–gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 57, 651–6.
   PubMed Web of Science ®Google Scholar
• Roilides, E, Sein, T, Holmes, A, Chanock, S, Blake, C, Pizzo, P A, and Walsh, T J 1995b. Effects of macrophage colony–stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 172, 1028–34.
   PubMed Web of Science ®Google Scholar
• Ross, I K, De Bernardis, F, Emerson, G W, Cassone, A, and Sullivan, P A 1990. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase–deficient mutant. J Gen Microbiol 136, 687–94.
   PubMedGoogle Scholar
• Roy, B, and Meyer, S A 1998. Confirmation of the distinct genotype groups within the form species Candida parapsilosis. J Clin Microbiol 36, 216–8.
   PubMed Web of Science ®Google Scholar
• Rubinstein, E, Noriega, E R, Simberkoff, M S, Holzman, R, and Rahal, J J, Jr 1975. Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine Baltimore. 54, 331–4.
   PubMed Web of Science ®Google Scholar
• Ruzicka, F, Hola, V, Votava, M, and Tejkalova, R 2007. Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method. Folia Microbiol (Praba). 52, 209–14.
   PubMed Web of Science ®Google Scholar
• Rycovska, A, Valach, M, Tomaska, L, Bolotin–Fukuhara, M, and Nosek, J 2004. Linear versus circular mitochondrial genomes: intraspecies variability of mitochondrial genome architecture in Candida parapsilosis. Microbiology 150, 1571–80.
   PubMed Web of Science ®Google Scholar
• Safdar, A, Perlin, D S, and Armstrong, D 2002. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades. Diagn Microbiol Infect Dis 44, 11–6.
   PubMed Web of Science ®Google Scholar
• Saiman, L, Ludington, E, Dawson, J D, Patterson, J E, Rangel–Frausto, S, Wiblin, R T, Blumberg, H M, Pfaller, M, Rinaldi, M, Edwards, J E, Wenzel, R P, and Jarvis, W 2001. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20, 1119–24.
   PubMed Web of Science ®Google Scholar
• Salo, J, Ribera, J M, Blade, J, Puig de la Bellacasa, J, Nomdedeu, B, Granena, A, and Rozman, C 1990. Sepsis caused by Candida parapsilosis joint and lung involvement in 2 patients with acute leukemia. Med Clin Barc. 94, 58–60.
   PubMedGoogle Scholar
• San Miguel, L G, Cobo, J, Otheo, E, Martos, I, Muriel, A, Fortun, J, and Moreno, S 2006. Candidemia in pediatric patients with congenital heart disease. Diagn Microbiol Infect Dis 55, 203–7.
   PubMed Web of Science ®Google Scholar
• San Miguel, L G, Cobo, J, Otheo, E, Sanchez–Sousa, A, Abraira, V, and Moreno, S 2005. Secular trends of candidemia in a large tertiary–care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect Control Hosp Epidemiol 26, 548–52.
   PubMed Web of Science ®Google Scholar
• Sanchez, V, Vazquez, J A, Barth–Jones, D, Dembry, L, Sobel, J D, and Zervos, M J 1993. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 94, 577–82.
   PubMed Web of Science ®Google Scholar
• Sandven, P 2000. Epidemiology of candidemia. Rev Iberoam Micol 17, 73–81.
   PubMedGoogle Scholar
• Sarvikivi, E, Lyytikainen, O, Soll, D R, Pujol, C, Pfaller, M A, Richardson, M, Koukila–Kahkola, P, Luukkainen, P, and Saxen, H 2005. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 43, 2729–35.
   PubMed Web of Science ®Google Scholar
• Saxen, H, Virtanen, M, Carlson, P, Hoppu, K, Pohjavuori, M, Vaara, M, Vuopio–Varkila, J, and Peltola, H 1995. Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J 14, 776–81.
   PubMed Web of Science ®Google Scholar
• Schaberg, D R, Culver, D H, and Gaynes, R P 1991. Major trends in the microbial etiology of nosocomial infection. Am J Med 91, 72S–75S.
   PubMed Web of Science ®Google Scholar
• Schar, G, Grehn, M, and von Graevenitz, A, 1990. Persistent colonization of carbon dioxide incubators with Candida parapsilosis. Eur J Clin Microbiol Infect Dis 9, 758–60.
   PubMed Web of Science ®Google Scholar
• Scherer, S, and Stevens, D A 1987. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol 25, 675–9.
   PubMed Web of Science ®Google Scholar
• Segal, E, Romano, A, Eylan, E, and Stein, R 1975. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections I In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections. Chemotherapy 21, 358–66.
   PubMed Web of Science ®Google Scholar
• Segal, R, Kimchi, A, Kritzman, A, Inbar, R, and Segal, Z 2000. The frequency of Candida parapsilosis in onychomycosis An epidemiological survey in Israel. Mycoses 43, 349–53.
   PubMed Web of Science ®Google Scholar
• Seidenfeld, S M, Cooper, B H, Smith, J W, Luby, J P, and Mackowiak, P A 1983. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. J Infect Dis 147, 116–9.
   PubMed Web of Science ®Google Scholar
• Shin, J H, Kee, S J, Shin, M G, Kim, S H, Shin, D H, Lee, S K, Suh, S P, and Ryang, D. W 2002. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40, 1244–8.
   PubMed Web of Science ®Google Scholar
• Shin, J H, Shin, D H, Song, J W, Kee, S J, Suh, S P, and Ryang, D W 2001. Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or recurrent fungemia. J Clin Microbiol 39, 1258–63.
   PubMed Web of Science ®Google Scholar
• Singh, B, Cutler, J C, and Utidjian, H M 1972. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections. and contraception 3 In vitro effect of vaginal contraceptive and selected vaginal preparations of Candida albicans and Trichomonas vaginalis. Contraception 5, 401–11.
   PubMed Web of Science ®Google Scholar
• Smith, S M, Lee, E Y, Cobbs, C J, and Eng, R H 1987. Unusual features of arthritis caused by Candida parapsilosis. Arch Pathol Lab Med 111, 71–3.
   PubMed Web of Science ®Google Scholar
• Sobel, J D, Muller, G, and Buckley, H R 1984. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun 44, 576–80.
   PubMed Web of Science ®Google Scholar
• Sofair, A N, Lyon, G M, Huie–White, S, Reiss, E, Harrison, L H, Sanza, L T, Arthington–Skaggs, B A, and Fridkin, S K 2006. Epidemiology of community–onset candidemia in Connecticut and Maryland. Clin Infect Dis 43, 32–9.
   PubMed Web of Science ®Google Scholar
• Soll, D R 1992. High–frequency switching in Candida albicans. Clin Microbiol Rev 5, 183–203.
   PubMed Web of Science ®Google Scholar
• Solomon, R, Biser, S A, Donnenfeld, E D, Perry, H D, Doshi, S J, and Lee, C C 2004. Candida parapsilosis keratitis following treatment of epithelial ingrowth after laser in situ keratomileusis. Eye Contact Lens 30, 85–6.
   PubMedGoogle Scholar
• Solomon, S L, Alexander, H, Eley, J W, Anderson, R L, Goodpasture, H C, Smart, S, Furman, R M, and Martone, W J 1986. Nosocomial fungemia in neonates associated with intravascular pressure–monitoring devices. Pediatr Infect Dis 5, 680–5.
   PubMedGoogle Scholar
• Solomon, S L, Khabbaz, R F, Parker, R H, Anderson, R L, Geraghty, M A, Furman, R M, and Martone, W J 1984. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 149, 98–102.
   PubMed Web of Science ®Google Scholar
• Song, J W, Shin, J H, Shin, D H, Jung, S I, Cho, D, Kee, S J, Shin, M G, Suh, S P, and Ryang, D W 2005. Differences in biofilm production by three genotypes of Candida parapsilosis from clinical sources. Med Mycol 43, 657–61.
   PubMed Web of Science ®Google Scholar
• Spellberg, B, and Edwards, J E 2002. The pathophysiology and treatment of Candida sepsis. Curr Infect Dis Rep 4, 387–99.
   PubMedGoogle Scholar
• Spellberg, B J, Filler, S G, and Edwards, J E, Jr 2006. Current treatment strategies for disseminated candidiasis. Clin Infect Dis 42, 244–51.
   PubMed Web of Science ®Google Scholar
• Stamos, J K, and Rowley, A H 1995. Candidemia in a pediatric population. Clin Infect Dis 20, 571–5.
   PubMed Web of Science ®Google Scholar
• Stern, W H, Tamura, E, Jacobs, R A, Pons, V G, Stone, R D, O’Day, D M, and Irvine, A R 1985. Epidemic postsurgical Candida parapsilosis endophthalmitis Clinical findings and management of 15 consecutive cases. Ophthalmol. 92, 1701–9.
   PubMed Web of Science ®Google Scholar
• Stevens, D A 1983. Fungal infections of the eye and their therapy, chapter 14. In, Antimicrobial Agents in Ophthalmology Edited by G Smolin & M Okumoto; Masson, publisher.
   Google Scholar
• Stevens, D A, Espiritu, M, and Parmar, R 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48, 3407–11.
   PubMed Web of Science ®Google Scholar
• Stevens, DA, Ichinomiya, M, Koshi, Y, Horiuchi, H 2006. Escape of Candida from caspofungin inhibition at supra–MIC concentrations (“paradoxical effect”) accomplished by increased cell wall chitin; evidence for beta–1,6–glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother 50, 3160–61.
   PubMed Web of Science ®Google Scholar
• Stevens, D A, White, T C, Perlin, D S, and Selitrennikoff, C P 2005. Studies of the paradoxical effect of caspofungin at high drug concentrations. Diagn Microbiol Infect Dis 51, 173–8.
   PubMed Web of Science ®Google Scholar
• Strausbaugh, L J, Sewell, D L, Ward, T T, Pfaller, M A, Heitzman, T, and Tjoelker, R 1994. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 32, 2299–300.
   PubMed Web of Science ®Google Scholar
• Sullivan, D J, Westerneng, T J, Haynes, K A, Bennett, D E, and Coleman, D C 1995. Candida dubliniensis sp nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV–infected individuals. Microbiol. 141, 1507–21.
   PubMed Web of Science ®Google Scholar
• Takao, S, Smith, E H, Wang, D, Chan, C K, Bulkley, G B, and Klein, A S 1996. Role of reactive oxygen metabolites in murine peritoneal macrophage phagocytosis and phagocytic killing. Am J Physiol 271, C1278–84.
   Google Scholar
• Tamura, N K, Gasparetto, A, and Svidzinski, T I 2003. Evaluation of the adherence of Candida species to urinary catheters. Mycopathol. 156, 269–72.
   PubMed Web of Science ®Google Scholar
• Tavanti, A, Davidson, A D, Gow, N A, Maiden, M C, and Odds, F C 2005. Candida orthopsilosis and Candida metapsilosis spp nov to replace Candida parapsilosis groups II and III. J Clin Microbiol 43, 284–92.
   PubMed Web of Science ®Google Scholar
• Tavanti, A, Hensgens, L A, Ghelardi, E, Campa, M, and Senesi, S 2007. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol 45, 1455–62.
   PubMed Web of Science ®Google Scholar
• Tonomo, K, Tsujino, T, Fujioka, Y, Nakao, S, Yao, H, Yasoshima, H, Kubota, A, Iwasaki, T, and Ohyanagi, M 2004. Candida parapsilosis endocarditis that emerged 2 years after abdominal surgery. Heart Vessels 19, 149–52.
   PubMed Web of Science ®Google Scholar
• Torres Perez, J D, Olea Cascon, J, Crespo Ortiz, P, Uriarte Estefania, F, Tortajada Goitia, B, and Perez–Salvador, J L 2004. Oral itraconazole for treatment of a Candida parapsilosis endophthalmitis case. Arch Soc Esp Oftalmol 79, 181–4.
   PubMedGoogle Scholar
• Tortorano, A M, Biraghi, E, Astolfi, A, Ossi, C, Tejada, M, Farina, C, Perin, S, Bonaccorso, C, Cavanna, C, Raballo, A, and Grossi, A 2002. European Confederation of Medical Mycology ECMM. prospective survey of candidaemia: report from one Italian region. J Hosp Infect 51, 297–304.
   PubMed Web of Science ®Google Scholar
• Tortorano, A M, Kibbler, C, Peman, J, Bernhardt, H, Klingspor, L, and Grillot, R 2006. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27, 359–66.
   PubMed Web of Science ®Google Scholar
• Tortorano, A M, Peman, J, Bernhardt, H, Klingspor, L, Kibbler, C C, Faure, O, Biraghi, E, Canton, E, Zimmermann, K, Seaton, S, and Grillot, R 2004. Epidemiology of candidaemia in Europe: results of 28–month European Confederation of Medical Mycology (ECMM) hospital–based surveillance study. Eur J Clin Microbiol Infect Dis 23, 317–22.
   PubMed Web of Science ®Google Scholar
• Tortorano, A M, Rigoni, A L, Biraghi, E, Prigitano, A, and Viviani, M A 2003. The European Confederation of Medical Mycology (ECMM). survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non–albicans Candida isolates from blood. J Antimicrob Chemother 52, 679–82.
   PubMed Web of Science ®Google Scholar
• Trama, J P, Adelson, M E, Raphaelli, I, Stemmer, S M, and Mordechai, E 2005. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol 13, 63–7.
   PubMedGoogle Scholar
• Traore, O, Springthorpe, V S, and Sattar, S A 2002. A quantitative study of the survival of two species of Candida on porous and non–porous environmental surfaces and hands. J Appl Microbiol 92, 549–55.
   PubMed Web of Science ®Google Scholar
• Trofa, D, Gacser, A, and Nosanchuk, J D 2008. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 21, 606–25.
   PubMed Web of Science ®Google Scholar
• van Asbeck, E C, Clemons, K V, Markham, A N, Stevens, D A, and Candida parapsilosis global epidemiology group 2008a. Molecular epidemiology of the global and temporal diversity of Candida parapsilosis Scand J Infect Dis. 40, 827–34.
   Google Scholar
• van Asbeck, E C, Clemons, K V, Martinez, M, Tong, A–J, and Stevens, D A 2008b. Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagn Microbiol Infect Dis 62, 106–9.
   PubMed Web of Science ®Google Scholar
• van Asbeck, E C, Hoepelman, A I, Scharringa, J, Herpers, B L, and Verhoef, J 2008c. Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol 8, 229–34.
   PubMed Web of Science ®Google Scholar
• van Asbeck, E, Hoepelman, A, Scharringa, J, Verhoef, J 2009. The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. Int J Antimicrob Agents 33, 21–6.
   PubMed Web of Science ®Google Scholar
• van Asbeck, E C, Huang, Y C, Markham, A N, Clemons, K V, and Stevens, D A 2007. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 164, 287–93.
   PubMed Web of Science ®Google Scholar
• van Asbeck, E C, Markham, A N, Clemons, K V, and Stevens, D A in press. Correlation of restriction fragment length polymorphism genotyping with internal transcribed spacer sequence, randomly amplified polymorphic DNA and multilocus sequence groupings for Candida parapsilosis. Mycoses.
   Web of Science ®Google Scholar
• van der Walt, J P 1966. Lodderomyces, a new genus of the Saccharomycetaceae. Antonie Van Leeuwenhoek 32, 1–5.
   PubMedGoogle Scholar
• Vasquez, J C, Hart, M, Denney, C F, Pedowitz, R, and Ziegler, E J 2002. Fungal arthritis of the knee caused by Candida parapsilosis in a kidney transplant recipient. J Clin Rheumatol 8, 147–50.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli, A, Bistoni, F, Cenci, E, Perito, S, and Cassone, A 1985. In–vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia 23, 377–87.
   PubMedGoogle Scholar
• Vella Zahra, L, Gatt, P, Boffa, M J, Borg, E, Mifsud, E, Scerri, L, Vella Briffa, D, and Pace, J.L 2003. Characteristics of superficial mycoses in Malta. Int J Dermatol 42, 265–71.
   PubMed Web of Science ®Google Scholar
• Vennewald, I, Schonlebe, J, and Klemm, E 2003. Mycological and histological investigations in humans with middle ear infections Mycoses 46, 12–8.
   PubMed Web of Science ®Google Scholar
• Viscoli, C, Girmenia, C, Marinus, A, Collette, L, Martino, P, Vandercam, B, Doyen, C, Lebeau, B, Spence, D, Krcmery, V, De Pauw, B, and Meunier, F 1999. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28, 1071–9.
   PubMed Web of Science ®Google Scholar
• Wada, M, Baba, H, and Imura, S 1998. Prosthetic knee Candida parapsilosis infection. J Arthroplasty 13, 479–82.
   PubMed Web of Science ®Google Scholar
• Wadlin, J K, Hanko, G, Stewart, R, Pape, J, and Nachamkin, I 1999. Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. J Clin Microbiol 37, 1967–70.
   PubMed Web of Science ®Google Scholar
• Wang, A Y, Yu, A W, Li, P K, Lam, P K, Leung, C B, Lai, K N, and Lui, S F 2000. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9year experience of fungal peritonitis in a single center. Am J Kidney Dis 36, 1183–92.
   PubMed Web of Science ®Google Scholar
• Weems, J J, Jr 1992. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 14, 756–66.
   PubMed Web of Science ®Google Scholar
• Weems, J J, Jr, Chamberland, M E, Ward, J, Willy, M, Padhye, A A, and Solomon, S L 1987. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 25, 1029–32.
   PubMed Web of Science ®Google Scholar
• Welbel, S F, McNeil, M M, Kuykendall, R J, Lott, T J, Pramanik, A, Silberman, R, Oberle, A D, Bland, L A, Aguero, S, Arduino, M, Crow, S, and Jarvis, W R 1996. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak. Pediatr Infect Dis J 15, 998–1002.
   PubMed Web of Science ®Google Scholar
• Wingard, J R 1995. Importance of Candida species other than C albicans as pathogens in oncology patients. Clin Infect Dis 20, 115–25.
   PubMed Web of Science ®Google Scholar
• Witt, M D, Imhoff, T, Li, C, and Bayer, A S 1993. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non–C albicans strains. Antimicrob Agents Chemother 37, 2030–2.
   PubMed Web of Science ®Google Scholar
• Wong, P N, Mak, S K, Lo, K Y, Tong, G M, and Wong, A K 2000. A retrospective study of seven cases of Candida parapsilosis peritonitis in CAPD patients: the therapeutic implications. Perit Dial Int 20, 76–9.
   PubMed Web of Science ®Google Scholar
• Yarchoan, R, Davies, S F, Fried, J, and Mahowald, M L 1979. Isolated Candida parapsilosis arthritis in a heroin addict. J Rheumatol 6, 447–50.
   PubMed Web of Science ®Google Scholar
• Yoder, B A, Sutton, D A, Winter, V, and Coalson, J J 2004. Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model. Pediatr Infect Dis J 23, 687–8.
   PubMed Web of Science ®Google Scholar
• Zancope–Oliveira, R M, James, M J, Derossi, A P, Sampaio, J L, Muniz, M M, Li, R K, Nascimento, A S, Peralta, J M, and Reiss, E 2000. Strain characterization of Candida parapsilosis fungemia by molecular typing methods. Eur J Clin Microbiol Infect Dis 19, 514–20.
   PubMed Web of Science ®Google Scholar
• Zhang, M X, Bohlman, M C, Itatani, C, Burton, D R, Parren, P W, St Jeor, S C, and Kozel, T R 2006. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect Immun 74, 362–9.
   PubMed Web of Science ®Google Scholar